# Bioequivalence Study of Clarithromycin 500 mg Tablets Under Non-Fasting Conditions

> **NCT00774696** · NA · COMPLETED · sponsor: **Ranbaxy Laboratories Limited** · enrollment: 24 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** clarithromycin 500mg tablets

## Key facts

- **NCT ID:** NCT00774696
- **Lead sponsor:** Ranbaxy Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2002-12
- **Final completion:** 2003-02
- **Target enrollment:** 24 (—)
- **Last updated:** 2008-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00774696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00774696, "Bioequivalence Study of Clarithromycin 500 mg Tablets Under Non-Fasting Conditions". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00774696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*